irganox 1010 has been researched along with bisphenol a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bercu, J; Binazon, O; Broschard, T; Bruen, U; Callis, CM; Cruz, MT; Dolan, DG; Erexson, GL; Giddings, A; Glowienke, S; Li, K; Martin, EA; Masuda-Herrera, M; Nagao, LM; Parris, P; Stanard, B; Stults, CLM; Whelan, G | 1 |
1 other study(ies) available for irganox 1010 and bisphenol a
Article | Year |
---|---|
Considerations when deriving compound-specific limits for extractables and leachables from pharmaceutical products: Four case studies.
Topics: Animals; Benzhydryl Compounds; Butylated Hydroxytoluene; Cricetinae; Decision Trees; Drug Contamination; Drug Packaging; Humans; Mice; Patient Safety; Pharmaceutical Preparations; Phenols; Phosphites; Rats; Risk Assessment; Toxicity Tests; Toxicokinetics | 2020 |